The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABIOMED INC | COM | 003654100 | 120,559 | 490,754 | SH | SOLE | 490,754 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 27,455 | 1,678,196 | SH | SOLE | 1,678,196 | 0 | 0 | ||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 859 | 160,800 | SH | SOLE | 160,800 | 0 | 0 | ||
ALIGN TECHNOLOGY INC | COM | 016255101 | 9,176 | 44,305 | SH | SOLE | 44,305 | 0 | 0 | ||
ALIMERA SCIENCES INC | COM | 016259202 | 1,021 | 200,919 | SH | SOLE | 200,919 | 0 | 0 | ||
ALKERMES PLC | COM | G01767105 | 13,474 | 603,400 | SH | SOLE | 603,400 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 102,811 | 9,847,774 | SH | SOLE | 9,847,774 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 10,995 | 431,024 | SH | SOLE | 431,024 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 96,382 | 360,981 | SH | SOLE | 360,981 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 167,528 | 1,976,265 | SH | SOLE | 1,976,265 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 5,324 | 4,473,967 | SH | SOLE | 4,473,967 | 0 | 0 | ||
CYTOKINETICS INC | COM | 23282W605 | 5,413 | 111,717 | SH | SOLE | 111,717 | 0 | 0 | ||
EHEALTH INC | COM | 28238P109 | 7,734 | 1,977,993 | SH | SOLE | 1,977,993 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 20,973 | 1,750,651 | SH | SOLE | 1,750,651 | 0 | 0 | ||
GRITSTONE ONCOLOGY INC | COM | 39868T105 | 5,989 | 2,330,504 | SH | SOLE | 2,330,504 | 0 | 0 | ||
INSMED INC | COM | 457669307 | 125,802 | 5,840,398 | SH | SOLE | 5,840,398 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 30,694 | 5,621,533 | SH | SOLE | 5,621,533 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 5,650 | 656,200 | SH | SOLE | 656,200 | 0 | 0 | ||
MAGENTA THERAPEUTICS INC | COM | 55910K108 | 610 | 432,300 | SH | SOLE | 432,300 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | COM | 56854Q200 | 208 | 31,330 | SH | SOLE | 31,330 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 1,359 | 64,700 | SH | SOLE | 64,700 | 0 | 0 | ||
PROTHENA CORP PLC | COM | G72800108 | 100,026 | 1,649,777 | SH | SOLE | 1,649,777 | 0 | 0 | ||
PROVENTION BIO INC | COM | 74374N102 | 1,759 | 390,800 | SH | SOLE | 390,800 | 0 | 0 | ||
REVANCE THERAPEUTICS INC | COM | 761330109 | 118,936 | 4,405,039 | SH | SOLE | 4,405,039 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 33,341 | 851,409 | SH | SOLE | 851,409 | 0 | 0 | ||
STAAR SURGICAL CO | COM | 852312305 | 77,385 | 1,096,882 | SH | SOLE | 1,096,882 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 14,721 | 612,600 | SH | SOLE | 612,600 | 0 | 0 | ||
TACTILE SYSTEMS TECHNOLOGY I | COM | 87357P100 | 211 | 27,100 | SH | SOLE | 27,100 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 4,092 | 166,069 | SH | SOLE | 166,069 | 0 | 0 | ||
UNITED THERAPEUTICS CORP | COM | 91307C102 | 132,649 | 633,534 | SH | SOLE | 633,534 | 0 | 0 | ||
UROGEN PHARMA LTD | COM | M96088105 | 204 | 24,500 | SH | SOLE | 24,500 | 0 | 0 | ||
VANDA PHARMACEUTICALS INC | COM | 921659108 | 21,402 | 2,166,156 | SH | SOLE | 2,166,156 | 0 | 0 |